Literature DB >> 25821331

Simultaneous inference of a misclassified outcome and competing risks failure time data.

Sheng Luo1, Xiao Su2, Min Yi3, Kelly K Hunt3.   

Abstract

Ipsilateral breast tumor relapse (IBTR) often occurs in breast cancer patients after their breast conservation therapy. The IBTR status' classification (true local recurrence versus new ipsilateral primary tumor) is subject to error and there is no widely-accepted gold standard. Time to IBTR is likely informative for IBTR classification because new primary tumor tends to have a longer mean time to IBTR and is associated with improved survival as compared with the true local recurrence tumor. Moreover, some patients may die from breast cancer or other causes in a competing risk scenario during the follow-up period. Because the time to death can be correlated to the unobserved true IBTR status and time to IBTR (if relapse occurs), this terminal mechanism is non-ignorable. In this article, we propose a unified framework that addresses these issues simultaneously by modeling the misclassified binary outcome without a gold standard and the correlated time to IBTR, subject to dependent competing terminal events. We evaluate the proposed framework by a simulation study and apply it to a real dataset consisting of 4, 477 breast cancer patients. The adaptive Gaussian quadrature tools in SAS procedure NLMIXED can be conveniently used to fit the proposed model. We expect to see broad applications of our model in other studies with a similar data structure.

Entities:  

Keywords:  Binary outcome; Diagnostic error; Imperfect tests; Latent class model; Sensitivity; Specificity

Year:  2015        PMID: 25821331      PMCID: PMC4372162          DOI: 10.1080/02664763.2014.995606

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.404


  17 in total

1.  Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests.

Authors:  N Dendukuri; L Joseph
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  Joint modelling of longitudinal measurements and event time data.

Authors:  R Henderson; P Diggle; A Dobson
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

3.  A cautionary note on the robustness of latent class models for estimating diagnostic error without a gold standard.

Authors:  Paul S Albert; Lori E Dodd
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

4.  Instrumental variables in the evaluation of diagnostic test procedures when the true disease state is unknown.

Authors:  N J Nagelkerke; V Fidler; M Buwalda
Journal:  Stat Med       Date:  1988-07       Impact factor: 2.373

5.  Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.

Authors:  Eugene Huang; Thomas A Buchholz; Funda Meric; Savitri Krishnamurthy; Nadeem Q Mirza; Frederick C Ames; Barry W Feig; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Marsha D McNeese; Eric A Strom; Kelly K Hunt
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

6.  Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.

Authors:  Yoshifumi Komoike; Futoshi Akiyama; Yuichi Iino; Tadashi Ikeda; Sadako Tanaka-Akashi; Shozo Ohsumi; Mikihiro Kusama; Muneaki Sano; Eisei Shin; Kimito Suemasu; Hiroshi Sonoo; Tetsuya Taguchi; Tunehiro Nishi; Reiki Nishimura; Shunsuke Haga; Keiichi Mise; Takayuki Kinoshita; Shigeru Murakami; Masataka Yoshimoto; Hideaki Tsukuma; Hideo Inaji
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

7.  True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.

Authors:  T E Smith; D Lee; B C Turner; D Carter; B G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

8.  Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

Authors:  Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Howard D Thames; Mary Jane Oswald; Elesyia D Outlaw; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Fredrick C Ames; Barry W Feig; Aysegul A Sahin; George H Perkins; Naomi R Schechter; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.

Authors:  Sheng Luo; Xiao Su; Stacia M DeSantis; Xuelin Huang; Min Yi; Kelly K Hunt
Journal:  Stat Med       Date:  2014-01-29       Impact factor: 2.373

10.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.